EOS Imaging (Formerly Known as biospace med) Expands Further into U.S. Market

Published: Nov 17, 2010

CAMBRIDGE, Mass., and PARIS, Nov. 18, 2010 - EOS imaging (www.eos-imaging.com) announced today that it is continuing to expand into the U.S. market with its breakthrough EOS low-dose, 2D|3D imaging system. Three new prestigious healthcare centers - Barnes-Jewish Hospital (St. Louis, Mo.), New York University (NY), and University of Iowa (Iowa City) - have adopted EOS for their musculoskeletal imaging suites.

In addition, the Company also announced that it has signed agreements with several orthopedic-imaging sales agents to support the sales momentum across the United States.

"We are very pleased with the continuing success that we are achieving in the United States for our EOS orthopedic imaging system," said Hervé Legrand, VP Sales & Marketing of EOS imaging. "These new sites are amongst the finest orthopedic centers in the world. The success of EOS results from the way radiologists and orthopedists can now, with EOS, diagnose and treat deformative and degenerative pathologies in all age groups, from children to geriatric patients."

"Without EOS, radiologists and orthopedists have had to interpret what they are looking at in a 2D x-ray," added Mr. Legrand. "But now, thanks to EOS, radiologists and orthopedists can view a patient's entire skeletal anatomy: life-sized, standing up, and in 3D from all angles. With the addition of these new preeminent orthopedic sites, EOS is further established as entirely new modality in orthopedic imaging, with extremely low x-ray exposure1 to the patient - and efficient patient workflow for the physician," said Mr. Legrand.

About the EOS product and the company EOS imaging

EOSwas developed from a Nobel Prize-winning technology by a team of engineers, orthopedic surgeons and radiologists as a complete orthopedic imaging solution. EOS allows full-body imaging of patients that enables global assessment of balance and posture as well as a 3D bone-envelope image in a weight-bearing position, and provides automatically over 100 clinical parameters to the orthopedic surgeon for pre- and post-operative surgical planning. EOS is a total solution in orthopedic imaging available in the U.S. since receiving FDA 510(k) clearance. The company EOS Imaging has corporate headquarters in Cambridge, Mass. (185 Alewife Brook Parkway, Suite 410; toll-free: +1-866-933-5301), and Paris, as well as an office in Montreal, and is targeting a $2 billion orthopedic imaging marketplace.

Learn more at: www.eos-imaging.com.

Back to news